Earnings Summary

STAAR Surgical Co’s revenue jumped 23.94% since last year same period to $58.35Mn in the Q4 2021. On a quarterly growth basis, STAAR Surgical Co has generated -6.44% fall in its revenue since last 3-months.

STAAR Surgical Co’s net profit jumped 54.68% since last year same period to $6.02Mn in the Q4 2021. On a quarterly growth basis, STAAR Surgical Co has generated -29.73% fall in its net profits since last 3-months.

STAAR Surgical Co’s net profit margin jumped 24.8% since last year same period to 10.32% in the Q4 2021. On a quarterly growth basis, STAAR Surgical Co has generated -24.9% fall in its net profit margins since last 3-months.

STAAR Surgical Co’s earning per share (EPS) estimates for the current quarter stand at 0.08 - a -38.46% fall from last quarter’s estimates.

STAAR Surgical Co’s earning per share (EPS) estimates for the current year stand at 0.08.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. STAAR Surgical Co’s return on assets (ROA) stands at 0.07.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. STAAR Surgical Co’s return on equity (ROE) stands at 0.13.